carbamates has been researched along with Debility in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"In elderly HCV patients, poor frailty status strongly predicted new LTCI certification after DAA therapy." | 1.62 | Frailty Status Predicts New Long-term Care Insurance Certification in Hepatitis C Patients Receiving Antiviral Therapy. ( Hasuike, S; Iwakiri, H; Kuroki, K; Kusumoto, K; Matsuura, Y; Mukuda, T; Nagata, K; Nakamura, K; Ochiai, T; Ozono, Y; Shimoda, K; Tsuchimochi, M, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, K | 1 |
Kusumoto, K | 1 |
Ozono, Y | 1 |
Kuroki, K | 1 |
Matsuura, Y | 1 |
Mukuda, T | 1 |
Ochiai, T | 1 |
Tsuchimochi, M | 1 |
Iwakiri, H | 1 |
Hasuike, S | 1 |
Shimoda, K | 1 |
Nagata, K | 1 |
1 other study available for carbamates and Debility
Article | Year |
---|---|
Frailty Status Predicts New Long-term Care Insurance Certification in Hepatitis C Patients Receiving Antiviral Therapy.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Eligibility Determination; Female; Frailty; H | 2021 |